News
COVID-19 – OTC Painkiller Demand Surge
Amid news reports of panic buying of paracetamol, the Executive Director of the Healthcare Distribution Association — the membership organisation […]
COVID-19 – UK Pharmaceutical Industry Response
The Association of the British Pharmaceutical Industry have today [16/03/20] launched a ‘Responding to COVID-19‘ webpage, with information about the […]
COVID-19 + ACE-Is or ARBs – European Society of Cardiology Position Statement
There has been speculation in medical journals, online discussion forums and elsewhere about a possible link between treatment with ACE-inhibitors […]
COVID-19 – NHSEI Prescription Advice
The NHS England and Improvement Medical Director for Primary Care, Dr Nikita Kanani, has issued a COVID-19 update to General […]
Nexplanon – New Insertion Site
The latest edition of Drug Safety Update from the MHRA reminds Healthcare Professionals that guidance on correct insertion of Nexplanon […]
Integrated Yellow Card Reporting – 93% GP coverage
The MHRA & EMIS have announced the roll-out of integrated reporting of suspected adverse drug reactions (ADRs) to the Yellow […]
Domperidone – No Longer Authorised for use in Children <12yrs
Following a European review of new evidence showing a lack of efficacy for domperidone for nausea & vomiting in children, […]
Drug Safety Update January 2020 – Reporting supected adverse events linked to e-cigarettes
The January 2020 edition of Drug Safety Update includes a reminder to be vigilant for any suspected adverse reactions associated […]
Medicines Support – HEE Training for Non-Registered Workforce
Health Education England have launched a set of training resources for the non-registered medicines workforce. To help people achieve essential […]